Compare TROW & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TROW | LH |
|---|---|---|
| Founded | 1937 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8B | 22.1B |
| IPO Year | N/A | N/A |
| Metric | TROW | LH |
|---|---|---|
| Price | $106.56 | $258.93 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 11 | 13 |
| Target Price | $106.55 | ★ $299.00 |
| AVG Volume (30 Days) | ★ 1.6M | 952.3K |
| Earning Date | 10-31-2025 | 10-28-2025 |
| Dividend Yield | ★ 4.77% | 1.11% |
| EPS Growth | 0.40 | ★ 98.36 |
| EPS | 9.17 | ★ 10.19 |
| Revenue | $7,205,200,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $5.40 | $10.82 |
| Revenue Next Year | $5.44 | $4.44 |
| P/E Ratio | ★ $11.63 | $25.37 |
| Revenue Growth | 4.25 | ★ 8.28 |
| 52 Week Low | $77.85 | $209.38 |
| 52 Week High | $125.81 | $293.72 |
| Indicator | TROW | LH |
|---|---|---|
| Relative Strength Index (RSI) | 64.89 | 41.12 |
| Support Level | $101.35 | $264.66 |
| Resistance Level | $103.11 | $272.82 |
| Average True Range (ATR) | 2.13 | 5.02 |
| MACD | 0.80 | -0.05 |
| Stochastic Oscillator | 95.26 | 4.62 |
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of July 2025, the firm had $1.703 trillion in managed assets, composed of equity (50%), balanced (35%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.